Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study.
Doi Y, Tsujita M, Hamano T, Obi Y, Namba-Hamano T, Tomosugi T, Futamura K, Okada M, Hiramitsu T, Goto N, Nishiyama A, Takeda A, Narumi S, Watarai Y, Isaka Y. Doi Y, et al. Among authors: futamura k. Am J Transplant. 2021 Sep;21(9):3043-3054. doi: 10.1111/ajt.16530. Epub 2021 Mar 6. Am J Transplant. 2021. PMID: 33565715 Free PMC article. Clinical Trial.
Death and kidney allograft dysfunction after bacteremia.
Ito K, Goto N, Futamura K, Okada M, Yamamoto T, Tsujita M, Hiramitsu T, Narumi S, Tominaga Y, Watarai Y. Ito K, et al. Among authors: futamura k. Clin Exp Nephrol. 2016 Apr;20(2):309-15. doi: 10.1007/s10157-015-1155-6. Epub 2015 Aug 26. Clin Exp Nephrol. 2016. PMID: 26307127
5-year follow-up of a randomized clinical study comparing everolimus plus reduced-dose cyclosporine with mycophenolate mofetil plus standard-dose cyclosporine in de novo kidney transplantation: Retrospective single center assessment.
Hiramitsu T, Okada M, Futamura K, Yamamoto T, Tsujita M, Goto N, Narumi S, Watarai Y, Takeda A, Iwasaki K, Uchida K, Kobayashi T. Hiramitsu T, et al. Among authors: futamura k. Int Immunopharmacol. 2016 Oct;39:192-198. doi: 10.1016/j.intimp.2016.07.019. Epub 2016 Aug 2. Int Immunopharmacol. 2016. PMID: 27491025 Clinical Trial.
Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
Yamamoto T, Watarai Y, Futamura K, Okada M, Tsujita M, Hiramitsu T, Goto N, Narumi S, Takeda A, Kobayashi T. Yamamoto T, et al. Among authors: futamura k. Transplant Proc. 2017 Jan-Feb;49(1):159-162. doi: 10.1016/j.transproceed.2016.10.013. Transplant Proc. 2017. PMID: 28104125
Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients.
Goto N, Takahashi-Nakazato A, Futamura K, Okada M, Yamamoto T, Tsujita M, Hiramitsu T, Narumi S, Tsuchiya K, Gatanaga H, Watarai Y, Oka S. Goto N, et al. Among authors: futamura k. Transplant Direct. 2017 Apr 5;3(5):e151. doi: 10.1097/TXD.0000000000000665. eCollection 2017 May. Transplant Direct. 2017. PMID: 28573186 Free PMC article.
Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.
Okada M, Watarai Y, Iwasaki K, Murotani K, Futamura K, Yamamoto T, Hiramitsu T, Tsujita M, Goto N, Narumi S, Takeda A, Morozumi K, Uchida K, Kobayashi T. Okada M, et al. Among authors: futamura k. Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13071. Epub 2017 Aug 29. Clin Transplant. 2017. PMID: 28792635
Triglyceride metabolism in Japanese kidney transplant recipients.
Tsujita M, Goto N, Futamura K, Okada M, Hiramitsu T, Narumi S, Watarai Y. Tsujita M, et al. Among authors: futamura k. Clin Exp Nephrol. 2018 Apr;22(2):459-464. doi: 10.1007/s10157-017-1462-1. Epub 2017 Aug 28. Clin Exp Nephrol. 2018. PMID: 28849320
121 results